Clinical Advisory Board
Geoffrey S. Baird, MD, Ph.D. - Chair
Dr. Baird is the Chair of the Avalon Clinical Advisory Board. He is board-certified in Anatomic and Clinical Pathology as well as Clinical Chemistry. Dr. Baird serves as both Interim Chair and Associate Professor of Laboratory Medicine as well as an Adjunct Associate Professor of Pathology at the University of Washington in Seattle, WA. He is the Laboratory Medical Director at Northwest Hospital and Airlift Northwest, and the Director of Clinical Chemistry at Harborview Medical Center. He was formerly the Associate Program Director of the UW Clinical Pathology Residency Program and Director of the UW Clinical Chemistry Fellowship Program.
Dr. Baird serves on numerous local and national committees, including the CMS/PAMA Clinical Diagnostic Laboratory Test Panel and ASCP's Choosing Wisely Campaign Committee where he has been instrumental in developing the ASCP's Choosing Wisely recommendations. He is the recipient of the AACC's Grannis Award for Excellence in Research and Scientific Publication and the International Federation of Clinical Chemistry's Young Investigator award.
Dr. Baird is a member of the Academy of Clinical Laboratory Physicians and Scientists. His clinical interests include rational laboratory test utilization, chemistry and toxicology, molecular diagnostics and proteomics.
Dr. Baird is a graduate of Stanford University with a BS in Chemistry. He received his MD and PhD at the University of California, San Diego, and did his residency in Anatomic and Clinical Pathology at the University of Washington in Seattle.
Timothy R. Hamill, MD
Dr. Timothy Hamill is the Prior Director of Clinical Laboratories at UCSF Medical Center's China Basin and Parnassus campuses. In addition, he is Professor Emeritus and Ex-Vice Chair of the UCSF Department of Laboratory Medicine.
Dr. Hamill has held numerous memberships in UCSF Medical Center committees in his tenure, including the position of chair of the UCSF Medical Center Point of Care Testing Committee. He is also past chair of the California Department of Health Services Clinical Laboratory Technology Advisory Committee (CLTAC). He is currently President and member of the Board for the California Society of Pathologists, and a fellow of the American Society of Clinical Pathologists and College of American Pathologists.
In his career, Dr. Hamill has taken a lead in promoting laboratory science as a career and clinical laboratory scientist training as the Co-Chair of the Hospital Laboratory Workforce Initiative of the California Hospital Association. In addition, he has also been involved in developing better point-of-care testing practices through the College of American Pathologists as the Vice-Chair of the Point of Care Testing Resource Committee.
Dr. Hamill completed his medical degree from UC Davis' School of Medicine. He was the chief resident in the departments of Laboratory Medicine at UCSF and San Francisco General Hospital. In addition, he completed a fellowship in Hematopathology at the Veterans Administration Medical Center in Martinez, CA. He is board-certified in clinical pathology and also hematopathology.
Victoria M. Pratt, Ph.D.
Dr. Pratt is a Medical and Clinical Molecular Geneticist board-certified by the American College of Medical Genetics. She is the Director of the Pharmacogenomics Laboratory at Indiana University School of Medicine. Prior to joining Indiana University, she was Chief Director, Molecular Genetics, for Quest Diagnostics Nichols Institute.
In addition to her work, Dr. Pratt is currently serving on the Centers for Medicare and Medicaid Services Clinical Diagnostic Laboratory Tests Advisory Panel. Dr. Pratt continues to serve on the CDC’s GeT-RM program for reference materials for Molecular Genetics. She is currently serving on the Institute of Medicine/National Academy of Medicine’s Roundtable on Translating Genomic-Based Research for Health and Committee on Policy Issues in the Clinical Development and Use of Biomarkers for Molecularly Targeted Therapies. She also served on the U.S. Secretary of Health and Human Services Advisory Committee on Genetics, Health and Society for the Oversight of Genetic Testing and the Advisory Committee on Hereditary Disorders in Newborns and Children. She also participated in the preparation of the Morbidity and Mortality Weekly Report for Best Practices in Molecular Genetic Testing for the Centers for Disease Control and Prevention (CDC).
Dr. Pratt is Past Chair of the Clinical Practice Committee and is currently a member of the Professional Relations committee, and is the chair of the Program committee for the Association of Molecular Pathology. She is a former advisor of EurogenTest for genetic test validation. Dr. Pratt serves on the American Medical Association’s (AMA’s) Molecular Pathology Current Procedural Terminology (CPT) Advisory committee.
Dr. Pratt has authored over 50 peer-reviewed manuscripts and book chapters. She is also an Associate Editor for the Journal of Molecular Pathology.
Dr. Pratt graduated with a Ph.D. in Medical and Molecular Genetics from Indiana University School of Medicine, Indianapolis, IN in 1994. Her fellowship training was in Ph.D. Medical and Clinical Molecular Genetics at Henry Ford Hospital, Detroit MI.
Brian P. Rubin, MD, Ph.D.
Dr. Rubin is Professor and Vice Chair of Pathology, Director, Soft Tissue Pathology, Director, Bone & Soft Tissue Pathology Fellowship Program, Staff, Department of Cancer Biology and Practicing Pathologist with sub-specialty expertise in bone and soft tissue tumors, Cleveland Clinic
Dr. Rubin is Staff, Department of Cancer Biology, Lerner Research Institute and Cleveland Clinic
Clinical Interests: Bone and Soft Tissue Tumor Diagnosis and Classification, Cancer Genetics, Digital Pathology, Molecular Pathology
Brian R. Smith, MD
Dr. Smith is Chair of the Department of Laboratory Medicine at the Yale School of Medicine and Professor of Laboratory Medicine, Biomedical Engineering, Internal Medicine and Pediatrics at Yale University. He is also the Chief of Laboratory Medicine at Yale New Haven Hospital.
Dr. Smith received his undergraduate degree from Princeton University, his medical degree from the Harvard Medical School, and his residency/fellowship training at The Brigham & Women’s Hospital, Boston Children’s Hospital, and Dana Farber Cancer Center. He is board certified in Pathology / Hematopathology and in Internal Medicine / Hematology-Oncology. He practices in all of his subspecialty areas. In addition to his clinical work, Dr. Smith has an investigative interest in the inflammation-coagulation interface, especially in relation to biomaterials, as well as in cellular immunotherapeutics, with over 175 publications. His educational activities include direction of an NIH-funded research training program in Immunohematology and Transfusion Medicine. He also lectures in the areas of biomedical ethics, “therapeutic pathology”, and in the education of the physician-scientist. Nationally, he has been member and chair for various NIH and American Heart Association research study sections, chair of the Association of Pathology Chairs Research Committee, and a member of the CDC Clinical Laboratory Integration into Healthcare Collaborative. He is the recipient of a number of Awards including Stohlman Scholar of the Leukemia & Lymphoma Society, National Blood Foundation Scholar, the Evans Award from the Academy of Clinical Laboratory Physicians and Scientists, and has served as a visiting professor at a number of universities.